Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Current Assets (2016 - 2025)

Historic Current Assets for Dexcom (DXCM) over the last 17 years, with Q4 2025 value amounting to $4.0 billion.

  • Dexcom's Current Assets fell 623.29% to $4.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $4.0 billion, marking a year-over-year decrease of 623.29%. This contributed to the annual value of $4.0 billion for FY2025, which is 623.29% down from last year.
  • Dexcom's Current Assets amounted to $4.0 billion in Q4 2025, which was down 623.29% from $5.2 billion recorded in Q3 2025.
  • Dexcom's Current Assets' 5-year high stood at $5.2 billion during Q3 2025, with a 5-year trough of $3.4 billion in Q3 2022.
  • Its 5-year average for Current Assets is $4.2 billion, with a median of $4.1 billion in 2024.
  • As far as peak fluctuations go, Dexcom's Current Assets soared by 7262.61% in 2021, and later crashed by 927.12% in 2024.
  • Over the past 5 years, Dexcom's Current Assets (Quarter) stood at $3.7 billion in 2021, then decreased by 0.42% to $3.7 billion in 2022, then rose by 20.64% to $4.4 billion in 2023, then fell by 2.81% to $4.3 billion in 2024, then dropped by 6.23% to $4.0 billion in 2025.
  • Its Current Assets was $4.0 billion in Q4 2025, compared to $5.2 billion in Q3 2025 and $5.0 billion in Q2 2025.